Discover sermorelin other names, including GRF 1-29, GHRH 1-44, and brand names like Geref, plus how these labels differ in research and clinical use.
Sermorelin is also known as GRF 1-29, GHRH 1-29, and sermorelin acetate, and it was once sold under the brand name Geref. All of those names describe the same 29-amino-acid peptide, a synthetic copy of the first 29 amino acids of growth hormone-releasing hormone (GHRH). The different labels come from research labs, pharmacies, and regulators rather than from any real difference in the molecule itself.
What Is Sermorelin Also Known As?
Sermorelin belongs to a small family of GHRH analogs, and each naming convention highlights a different detail: the fragment length, the salt form, or the commercial brand.
| Name | Type of Name | Where You Usually See It |
|---|---|---|
| Sermorelin | Generic (INN/USAN) | Drug references, clinical studies, FDA documents |
| GRF 1-29 | Research shorthand | Peptide catalogs, laboratory protocols |
| GHRH 1-29 | Scientific descriptor | Endocrinology journals, PubMed abstracts |
| Sermorelin acetate | Salt form | Compounding pharmacy labels, package inserts |
| Geref | Brand name (discontinued) | Older prescribing information, FDA archives |
| GRF (1-29) NH2 | Chemical notation | Certificates of analysis, research documentation |
If you see "GRF 1-29" on a research vendor's certificate of analysis and "sermorelin acetate" on a compounding pharmacy label, you are looking at the same peptide. Online threads such as sermorelin acetate reddit often blend all of these labels together, which is a major reason the naming feels so confusing.
Why One Peptide Has So Many Names
Three naming systems overlap for this compound, and each one serves a different audience.
- Regulatory names. "Sermorelin" is the international nonproprietary name (INN) and the United States Adopted Name. Official drug references use this version.
- Research names. Scientists describe the molecule by its structure, such as GRF 1-29 or GHRH (1-29), because the fragment length matters in a laboratory setting.
- Brand and marketing names. Geref was the original prescription brand. Today, sellers invent their own product names, which adds another layer of confusion.
Chemical synonyms like GRF (1-29) NH2 appear mostly in lab documentation and rarely signal anything different to a buyer. A different label does not mean a different peptide.
Names That Are Not Sermorelin
Several peptides get lumped in with sermorelin because they all touch the growth hormone pathway. They are not the same compound, and they do not behave the same way in the body.
| Peptide | What It Is | Key Difference From Sermorelin |
|---|---|---|
| Sermorelin | GHRH analog (first 29 amino acids) | Short-acting; mirrors natural GHRH signaling |
| CJC-1295 | GHRH analog with a drug-affinity complex | Substantially longer half-life |
| Ipamorelin | Ghrelin receptor agonist | Works through a different receptor than GHRH |
| Tesamorelin | Full-length GHRH analog | FDA-approved for HIV-related lipodystrophy |
| GHRP-6 | Ghrelin receptor agonist | Commonly associated with increased appetite |
| IGF-1 LR3 | Modified insulin-like growth factor 1 | Acts downstream of growth hormone, not at the pituitary |
Because these peptides are discussed together so often, people search for combined protocols such as sermorelin ipamorelin cjc1295 dosage even though each compound has its own profile. In the same way, an igf-1 lr3 vs sermorelin comparison is really about two different points on one hormonal chain: sermorelin acts upstream at the pituitary, while IGF-1 LR3 acts downstream.
What the Names Do Not Change
A new label does not change a peptide's legal status or its safety profile. Sermorelin is not FDA-approved for general human use in the United States today; the original Geref product was cleared only as a diagnostic agent and has been discontinued for years.
Sermorelin is also banned by the World Anti-Doping Agency for athletes in competition. Side effects reported in clinical literature include injection-site reactions, flushing, and headache, and anyone considering it should speak with a licensed healthcare professional first.
Practical questions come up no matter what name is printed on the vial. A common one is how long does sermorelin take to work, and another is whether sermorelin and glp-1 together makes sense for a given patient. Those are clinical judgment calls that depend on your history, labs, and goals.
How to Compare Products When Names Overlap
- Match the chemical name, not the marketing name. Look for sermorelin, GRF 1-29, or GHRH (1-29) on the label.
- Confirm the fragment length. Sermorelin is the 1-29 fragment. A product described only as "GHRH" without a number is ambiguous.
- Check the salt form. Sermorelin acetate is the common form, and the acetate is not a separate drug.
- Ask for third-party testing. Independent purity and identity testing matters far more than a catchy product name.
- Be skeptical of proprietary blends. Blends hide doses and make it impossible to know which peptide you are actually getting.
Key Takeaways
- Sermorelin, GRF 1-29, GHRH 1-29, and sermorelin acetate all refer to the same peptide.
- Geref was the original brand name for sermorelin and is no longer marketed.
- CJC-1295, ipamorelin, tesamorelin, GHRP-6, and IGF-1 LR3 are different molecules, not alternative names for sermorelin.
- Sermorelin is not FDA-approved for general human use in the United States.
- Naming differences rarely reflect meaningful quality differences; testing and sourcing do.
Frequently Asked Questions
What is another name for sermorelin?
Sermorelin is also called GRF 1-29, GHRH 1-29, and sermorelin acetate, and it was formerly sold under the brand name Geref. All of these names refer to the same 29-amino-acid fragment of growth hormone-releasing hormone.
Is sermorelin the same as CJC-1295 or ipamorelin?
No. Sermorelin is a short-acting GHRH fragment, CJC-1295 is a longer-acting GHRH analog, and ipamorelin is a ghrelin receptor agonist. They are separate molecules with different half-lives and different receptor targets.
Is sermorelin FDA-approved?
Sermorelin was approved as Geref for diagnostic testing of growth hormone deficiency, but that product has been discontinued. Sermorelin is not FDA-approved today for anti-aging or general therapeutic use, and compounded versions are not FDA-approved either.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.